Aberrant HBP flux in cancer, driven by dysregulation of GFPT, is associated with various aspects of cancer progression, including enhanced proliferation, survival, self-renewal, and metastasis (Fig. 6 and Table 2). This evidence concerns the gene GFPT1 and cancer.